Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Moringa concanensis

ABSTRACT: Moringa concanensis Transcriptome or Gene expression

PROVIDER: PRJNA665353 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12717636_1.fastq.gz	Fastqsanger.gz
	SRR12717636_2.fastq.gz	Fastqsanger.gz
	SRR12717637_1.fastq.gz	Fastqsanger.gz
	SRR12717637_2.fastq.gz	Fastqsanger.gz
	SRR12717638_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 60

Similar Datasets

Moringa oleifera

Project description:Moringa oleifera Transcriptome or Gene expression

| PRJNA391762 | ENA

Moringa oleifera

Project description:Moringa oleifera Transcriptome or Gene expression

| PRJNA288608 | ENA

Moringa oleifera

Project description:Moringa oleifera Organism overview

| PRJNA304048 | ENA

Moringa oleifera cultivar:Bhagya (KDM-01)

Project description:Moringa oleifera cultivar:Bhagya (KDM-01) Transcriptome or Gene expression

| PRJNA394193 | ENA

Moringa oleifera

Project description:Moringa oleifera Raw sequence reads

| PRJNA835993 | ENA

Moringa oleifera

Project description:Moringa oleifera Genome sequencing and assembly

| PRJNA765934 | ENA

Moringa isothiocyanate-1 inhibits inflammation via NF-κB pathway in skeletal muscle cells

Project description:This study aims to investigate the effect of Moringa isothiocyanate-1 (MIC-1) derived from seeds of Moringa oleifera Lam in lipopolysaccharide (LPS)-induced muscle inflammation models. MIC-1 decreased nitric oxide production, and reduced the expression of pro-inflammatory markers, in C2C12 myoblasts. The daily oral treatment of MIC-1 (80 mg/kg) for three days significantly reduced the expression of pro-inflammatory markers (TNF-α, Ifn-α, IL-1β, IL-6) in gastrocnemius tissue of mice. Transcriptomic analysis provided insight into the inhibitory effects of MIC-1 on the LPS-induced inflammation, which suggests that MIC-1 acts via inflammation, and immunity pathways in myoblasts and skeletal muscle tissue. MIC-1 inhibited the nuclear accumulation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in the LPS-treated murine, which supports that MIC-1 decreases inflammation and regulates immune responses at a gene expression level in LPS-induced inflammation murine model.

2022-07-28 | GSE209706 | GEO

Moringa isothiocyanate-1 regulates Nrf2 and NF-κB Pathway in response to LPS-driven sepsis and inflammation

Project description:Moringa Isothiocyanate-1 (MIC-1) purified from moringa (Moringa oleifera Lam) seed extract (MSE) has been previously proved to modulate anti-inflammatory and antioxidant activities. However, the molecular mechanism remains poorly understood, particularly nothing is known about its effect on Lipopolysaccharide (LPS) induced sepsis/inflammation. Hence, we investigated whether MIC-1 can decrease acute inflammation in the LPS-induced acute inflammation/sepsis model in mice. Mice were treated orally with MIC-1 for three days before the intraperitoneal injection of LPS. MIC-1 treatment resulted in a dramatic improvement in the histopathological signs of inflammation in the liver, kidney, spleen, and colon and a significant reduction of the LPS-induced sepsis. Moreover, MIC-1 treatment significantly reduced the expression of inflammatory markers in all these organs. We also performed transcriptome analysis in vitro and in vivo in LPS induced macrophages and liver with/without MIC-1 treatment. Interestingly, there is an upregulation of inflammatory/immune response genes in LPS induced macrophages/liver, and there is downregulation of same set of genes after treating with MIC-1. Our results together indicate that MIC-1 reduces sepsis/inflammation through NF-κB and Nrf2 mediated anti-inflammatory/antioxidant signaling pathways. Research has demonstrated that chronic low-grade tissue inflammation and oxidative stress are essential factors in the development of metabolic disorders. Therefore, MIC-1 could be a new natural therapeutic strategy to treat metabolic syndrome.

2021-04-07 | GSE155738 | GEO

Exogenous miRNAs from Moringa oleifera Lam. recover a dysregulated lipid metabolism (human)

Project description:The efficacy of a traditional remedy was tested, based on an aqueous extract of Moringa oleifera Lam. seeds (MOES). Then, the miRNAs have been extracted from the MOES (mol-miR pool) and used for the treatments. Two tissues, in particular, were analyzed: the liver and the adipose tissue, both in vitro (HepG2 and 3T3-L1) and in vivo (C57BL/6J mice) models.

2019-01-19 | GSE125344 | GEO

Moringa oleifera concentrate as a complementary treatment in triple negative breast cancer

Project description:Using a rodent xenograft model of triple negative breast cancer (MDA-MB-231 cells), diet induced obesity, and insulin resistance, the aim of this study is to evaluate the effects of moringa (MC) on improving insulin sensitivity and inhibiting angiogenesis as a dual mechanism by which the efficacy of antineoplastic treatment by standard of care chemotherapy is augmented in vivo.

2021-10-06 | GSE178973 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data